- Report
- January 2023
- 52 Pages
Global
From €3787EUR$3,995USD£3,163GBP
- Report
- October 2018
- 50 Pages
Global
From €3313EUR$3,495USD£2,767GBP
- Report
- March 2025
- 87 Pages
China
From €1706EUR$1,800USD£1,425GBP
- Report
- March 2025
- 73 Pages
China
From €1706EUR$1,800USD£1,425GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1896EUR$2,000USD£1,584GBP
- Report
- February 2024
- 245 Pages
Global
€4734EUR$4,995USD£3,955GBP
- Report
- September 2022
- 342 Pages
Global
From €9004EUR$9,500USD£7,522GBP
- Report
- September 2022
- 160 Pages
Global
From €4502EUR$4,750USD£3,761GBP
- Report
- August 2022
United States
From €1839EUR$1,940USD£1,536GBP
- Report
- August 2021
Global
From €3782EUR$3,990USD£3,159GBP
- Report
- August 2021
Europe
From €3242EUR$3,420USD£2,708GBP
- Report
- February 2021
Global
From €2806EUR$2,960USD£2,344GBP
- Report
- November 2024
- 89 Pages
Global
From €3500EUR$3,956USD£3,026GBP
- Report
- February 2024
- 86 Pages
Global
From €3500EUR$3,956USD£3,026GBP
- Report
- October 2023
- 94 Pages
Global
From €3500EUR$3,956USD£3,026GBP
- Report
- September 2023
- 79 Pages
Global
From €3500EUR$3,956USD£3,026GBP
- Report
- July 2023
- 113 Pages
Global
From €3500EUR$3,956USD£3,026GBP
- Report
- February 2024
- 87 Pages
Global
From €3500EUR$3,956USD£3,026GBP
- Report
- March 2022
- 98 Pages
Global
From €3500EUR$3,956USD£3,026GBP
- Report
- January 2024
- 80 Pages
Vietnam
From €1422EUR$1,500USD£1,188GBP

The Anti-Obesity Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs designed to reduce or prevent obesity. These drugs are typically prescribed to individuals who are overweight or obese and are at risk of developing health complications due to their weight. Commonly prescribed anti-obesity drugs include orlistat, lorcaserin, and phentermine. These drugs work by suppressing appetite, increasing metabolism, or blocking the absorption of fat.
The Anti-Obesity Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Novo Nordisk, Sanofi, Pfizer, and Merck. These companies are constantly developing new drugs and treatments to meet the needs of their customers. Show Less Read more